Product Information

MESALAMINE DR 1.2 GM TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.7607 per EA under NDC 00591224522. Its NADAC has been published 441 times since Jun 13, 2018.

FDA first approved this application on Mar 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MESALAMINE DR 1.2 GM TABLET

Mesalamine
$0.7607per EA

Strength

1.2 g/1

NDC

00591224522

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MESALAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA203817

FDA Approved

3/23/2018

TE Code

AB

On Market Since

3/26/2018

Pharmacological Classes

Aminosalicylate
Aminosalicylic Acids

Price Statistics

The NADAC for MESALAMINE DR 1.2 GM TABLET has been published 441 times since Jun 13, 2018, and over the history we have for it it has declined 88.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7607 per EA
All-time high$6.7753 (Jun 13, 2018)
All-time low$0.7416 (Oct 21, 2026)
52-week high$0.8960
52-week low$0.7416
Median price$2.5900
Average price$2.5708
Largest weekly change+45.9% (Aug 21, 2024)
Weeks tracked441
Tracking sinceJun 13, 2018

Price History

1W

+2.6%

1M

-2.6%

3M

-4.4%

6M

-11.1%

1Y

-14.2%

3Y

-60.7%

5Y

-75.8%

All

-88.8%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MESALAMINE DR 1.2 GM TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE DR 1.2 GM TABLET, manufactured by Actavis Pharma, Inc., is $0.7607 per EA (NDC 00591224522), effective Nov 18, 2026.

How has the price of MESALAMINE DR 1.2 GM TABLET changed over time?

Over the history we have for it, the NADAC for MESALAMINE DR 1.2 GM TABLET has declined 88.8%. It has been tracked across 441 weekly CMS publications since Jun 13, 2018.

What are the highest and lowest recorded NADAC prices for MESALAMINE DR 1.2 GM TABLET?

Since Jun 13, 2018, the NADAC for MESALAMINE DR 1.2 GM TABLET has ranged from a low of $0.7416 (Oct 21, 2026) to a high of $6.7753 (Jun 13, 2018), with a median of $2.5900 per EA.

Are there cheaper alternatives to MESALAMINE DR 1.2 GM TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MESALAMINE DR 1.2 GM TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MESALAMINE DR 1.2 GM TABLET?

MESALAMINE DR 1.2 GM TABLET (NDC 00591224522) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.